Minardo John Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

Minardo John is Chief Legal Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 408,132 shares of IRWD, which is worth approximately $616,279. The most recent transaction as insider was on Feb 10, 2025, when has been sold 38,938 shares (Class A Common Stock) at a price of $1.76 per share, resulting in proceeds of $68,530. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 408K

43.37% 3M change

30.82% 12M change

Total Value Held $616,279

Minardo John Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2025	SELL Open market or private sale	$68,530 $1.76 p/Share	38,938 Reduced 8.71%	408,132 Class A Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	122,222 Added 21.47%	447,070 Class A Common Stock
Jan 17 2025	BUY Grant, award, or other acquisition	-	40,187 Added 11.01%	324,848 Class A Common Stock
Aug 12 2024	SELL Open market or private sale	$42,315 $4.27 p/Share	9,910 Reduced 3.36%	284,661 Class A Common Stock
May 20 2024	SELL Open market or private sale	$112,255 $6.45 p/Share	17,404 Reduced 5.58%	294,571 Class A Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	-	32,752 Added 9.5%	311,975 Class A Common Stock
Feb 12 2024	SELL Open market or private sale	$722,071 $15.24 p/Share	47,380 Reduced 17.41%	224,796 Class A Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	54,427 Added 16.31%	279,223 Class A Common Stock
Jan 17 2024	BUY Grant, award, or other acquisition	-	79,981 Added 22.71%	272,176 Class A Common Stock
Aug 14 2023	SELL Open market or private sale	$70,731 $10.04 p/Share	7,045 Reduced 3.54%	192,195 Class A Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	65,502 Added 24.74%	199,240 Class A Common Stock
Feb 28 2023	SELL Open market or private sale	$38,623 $11.31 p/Share	3,415 Reduced 2.49%	133,738 Class A Common Stock
Feb 27 2023	SELL Open market or private sale	$37,447 $11.41 p/Share	3,282 Reduced 2.34%	137,153 Class A Common Stock
Aug 15 2022	SELL Open market or private sale	$86,274 $11.77 p/Share	7,330 Reduced 4.96%	140,435 Class A Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	67,873 Added 31.48%	147,765 Class A Common Stock
Aug 02 2021	BUY Grant, award, or other acquisition	-	79,892 Added 50.0%	79,892 Class A Common Stock

Minardo John

Chief Legal Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Value

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

Operation

Value

Type

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Track Activities on IRWD

Account